Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 3M Licenses IRM Molecule to Spirig Pharma | Contract Pharma

What are you searching for?

Sign in
Breaking News

3M Licenses IRM Molecule to Spirig Pharma

3M Drug Delivery Systems has signed an exclusive license agreement with Spirig Pharma AG, a Swiss manufacturer of dermatological and dermocosmetic products.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

3M Drug Delivery Systems has signed an exclusive license agreement with Spirig Pharma AG, a Swiss manufacturer of dermatological and dermocosmetic products. Spirig will use one of 3M’s immune response modifier (IRM) molecules for the development of a treatment for sun-damaged skin.

Mark Tomai, Ph.D., vaccine business development director for 3M Drug Delivery Systems, said, “The molecule offers potential for treating patients that suffer from a variety of dermatologic conditions. 3M is very proud of the many IRMs we have been developing for a variety of uses.”

“We are excited to expand our franchise of dermatology offerings in the prevention and treatment of sun damage-related skin conditions,” said Dr. Silvio Inderbitzin, chief executive officer of Spirig Pharma AG. “With 3M’s IRM molecule, we can enhance our portfolio with the help of an experienced partner in drug delivery technologies.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics